|
For 30 years, Genentech has been at the forefront of the biotechnology industry, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. A considerable number of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes multiple biotechnology products providing innovative treatments for cancer, heart disease, and respiratory and growth disorders. With our world-renowned research organization, unparalleled development and manufacturing capabilities, highly sophisticated commercial organization, and more than 6600 competent, creative and enthusiastic employees, Genentech continues to transform the possibilities of biotechnology into improved realities for patients. The company is headquartered in South San Francisco, California and traded on the New York Stock Exchange under the symbol DNA. For more general information about the company, visit our website at: www.gene.com. |